{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:16:35Z","timestamp":1788182195852,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["24ZR1459200"],"award-info":[{"award-number":["24ZR1459200"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016983","name":"Shanghai Clinical Research Center","doi-asserted-by":"publisher","award":["19MC1910800"],"award-info":[{"award-number":["19MC1910800"]}],"id":[{"id":"10.13039\/501100016983","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077079"],"award-info":[{"award-number":["22077079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470025"],"award-info":[{"award-number":["81470025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82361148715"],"award-info":[{"award-number":["82361148715"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2122002"],"award-info":[{"award-number":["T2122002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Municipality Science and Technology Commission","doi-asserted-by":"publisher","award":["22Z510202478"],"award-info":[{"award-number":["22Z510202478"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Municipality Science and Technology Commission","doi-asserted-by":"publisher","award":["21Y31900402"],"award-info":[{"award-number":["21Y31900402"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR5014"],"award-info":[{"award-number":["SHDC2020CR5014"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["21SG10"],"award-info":[{"award-number":["21SG10"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["2019CXJQ03"],"award-info":[{"award-number":["2019CXJQ03"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["ZWB-1001-CPJS10"],"award-info":[{"award-number":["ZWB-1001-CPJS10"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymthe.2026.01.015","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:25:36Z","timestamp":1768926336000},"page":"3674-3697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prosaposin is a dual-action therapeutic target for vascular stabilization and neuroprotection"],"prefix":"10.1016","volume":"34","author":[{"given":"Jianhao","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao Jiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RenBing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1549-3499","authenticated-orcid":false,"given":"Xianting","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.01.015_bib1","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ymthe.2020.06.029","article-title":"Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update","volume":"28","author":"Lin","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.015_bib2","article-title":"Integrating genetics and metabolomics from multi-ethnic and multi-fluid data reveals putative mechanisms for age-related macular degeneration","volume":"4","author":"Han","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ymthe.2026.01.015_bib3","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)31559-2","article-title":"Retinal vascular occlusions","volume":"396","author":"Scott","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.ymthe.2026.01.015_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bjophthalmol-2017-311258","article-title":"Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections","volume":"102","author":"Bourne","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.01.015_bib5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.01.015_bib6","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.01.015_bib7","article-title":"Diabetic retinopathy","volume":"2","author":"Wong","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2026.01.015_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.01.015_bib9","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ymthe.2025.01.038","article-title":"Pharmacological blocking of microfibrillar-associated protein 4 reduces retinal neoangiogenesis and vascular leakage","volume":"33","author":"Schlosser","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.015_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","article-title":"Mechanisms of macular edema: Beyond the surface","volume":"63","author":"Daruich","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2026.01.015_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100921","article-title":"Sustained suppression of VEGF for treatment of retinal\/choroidal vascular diseases","volume":"83","author":"Campochiaro","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2026.01.015_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","article-title":"Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions","volume":"34","author":"Klaassen","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2026.01.015_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular endothelial growth factor a in intraocular vascular disease","volume":"120","author":"Miller","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.01.015_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cytogfr.2017.11.005","article-title":"Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: Current research and future perspectives","volume":"39","author":"Mesquita","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ymthe.2026.01.015_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molmed.2014.10.005","article-title":"Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye","volume":"21","author":"Sene","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2026.01.015_bib16","article-title":"Targeting cell-type-specific, choroid-peripheral immune signaling to treat age-related macular degeneration","volume":"5","author":"Lin","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ymthe.2026.01.015_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrd.2015.17","article-title":"Ten years of anti-vascular endothelial growth factor therapy","volume":"15","author":"Ferrara","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.01.015_bib18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ymthe.2026.01.015_bib19","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2019.5790","article-title":"Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial","volume":"321","author":"Baker","year":"2019","journal-title":"Jama"},{"key":"10.1016\/j.ymthe.2026.01.015_bib20","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial","volume":"314","author":"Gross","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.ymthe.2026.01.015_bib21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ajo.2014.11.022","article-title":"One-year outcomes of aflibercept in recurrent or persistent neovascular age-related macular degeneration","volume":"159","author":"Arcinue","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.01.015_bib22","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/bjophthalmol-2020-318672","article-title":"Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study","volume":"106","author":"Bulirsch","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.01.015_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14837","article-title":"Long-acting protein drugs for the treatment of ocular diseases","volume":"8","author":"Ghosh","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.01.015_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.exer.2019.01.001","article-title":"Decorin antagonizes corneal fibroblast migration via caveolae-mediated endocytosis of epidermal growth factor receptor","volume":"180","author":"Mohan","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2026.01.015_bib25","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2174\/1381612826666200114104342","article-title":"Neuroprotective and Neurorestorative Effects of Epo and VEGF: Perspectives for New Therapeutic Approaches to Neurological Diseases","volume":"26","author":"Ure\u00f1a-Guerrero","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymthe.2026.01.015_bib26","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/STROKEAHA.111.000240","article-title":"Vascular endothelial growth factor promotes pericyte coverage of brain capillaries, improves cerebral blood flow during subsequent focal cerebral ischemia, and preserves the metabolic penumbra","volume":"44","author":"Zechariah","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.ymthe.2026.01.015_bib27","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/IAE.0000000000000056","article-title":"Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration","volume":"34","author":"Doguizi","year":"2014","journal-title":"Retina (Philadelphia, Pa.)"},{"key":"10.1016\/j.ymthe.2026.01.015_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ophtha.2017.08.039","article-title":"Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration","volume":"125","author":"Invernizzi","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.01.015_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2026.01.015_bib30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/bjophthalmol-2012-302451","article-title":"Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema","volume":"97","author":"Zehetner","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.01.015_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","article-title":"HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration","volume":"127","author":"Dugel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.01.015_bib32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2023.12.026","article-title":"Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials","volume":"131","author":"Wong","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.01.015_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112436","article-title":"New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)","volume":"10","author":"Patel","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymthe.2026.01.015_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12964-022-00838-y","article-title":"Cancer combination therapies by angiogenesis inhibitors; a comprehensive review","volume":"20","author":"Ansari","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ymthe.2026.01.015_bib35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40259-021-00499-2","article-title":"Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update","volume":"35","author":"Parravano","year":"2021","journal-title":"BioDrugs."},{"key":"10.1016\/j.ymthe.2026.01.015_bib36","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41591-022-01862-8","article-title":"Regenerative and restorative medicine for eye disease","volume":"28","author":"Van Gelder","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.01.015_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314759","article-title":"Recent Advances in Proteomics-Based Approaches to Studying Age-Related Macular Degeneration: A Systematic Review","volume":"23","author":"Garc\u00eda-Quintanilla","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.01.015_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18050907","article-title":"A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders","volume":"18","author":"Cehofski","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.01.015_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.preteyeres.2013.01.004","article-title":"A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration","volume":"35","author":"Tezel","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2026.01.015_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007616","article-title":"IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration","volume":"6","author":"Doyle","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.01.015_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.01.015_bib42","article-title":"Tie2 activation promotes choriocapillary regeneration for alleviating neovascular age-related macular degeneration","volume":"5","author":"Kim","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.01.015_bib43","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nmeth.4346","article-title":"Principal component analysis","volume":"14","author":"Lever","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.01.015_bib44","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0140-6736(17)30544-5","article-title":"Cataracts","volume":"390","author":"Liu","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.ymthe.2026.01.015_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2026.01.015_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s12886-020-01684-7","article-title":"Angiogenin, FGF-\u03b1, and IL-36\u03b2 have higher expression levels in aqueous humor of nAMD patients in comparison to cataract patients","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.01.015_bib47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00006982-200510000-00015","article-title":"EXPRESSION OF CONNECTIVE TISSUE GROWTH FACTOR AND ITS POTENTIAL ROLE IN CHOROIDAL NEOVASCULARIZATION","volume":"25","author":"Watanabe","year":"2005","journal-title":"RETINA"},{"key":"10.1016\/j.ymthe.2026.01.015_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ophtha.2008.09.037","article-title":"Association of vitreous inflammatory factors with diabetic macular edema","volume":"116","author":"Funatsu","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.01.015_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.lfs.2015.06.017","article-title":"Possible role of endostatin in the antiangiogenic therapy of diabetic retinopathy","volume":"135","author":"Behl","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2026.01.015_bib50","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1089\/jop.2015.0023","article-title":"Thrombospondin-1 and Pathogenesis of Age-Related Macular Degeneration","volume":"31","author":"Housset","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.015_bib51","first-page":"2861","article-title":"Cell adhesion molecule expression in cultured human iris endothelial cells","volume":"42","author":"Silverman","year":"2001","journal-title":"Invest Ophth Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.01.015_bib52","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1167\/iovs.11-9417","article-title":"Correlations between Tear Cytokines, Chemokines, and Soluble Receptors and Clinical Severity of Dry Eye Disease","volume":"53","author":"Na","year":"2012","journal-title":"Invest Ophth Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.01.015_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3164734","article-title":"The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults","volume":"2016","author":"Nita","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ymthe.2026.01.015_bib54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11154-008-9090-4","article-title":"Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives","volume":"9","author":"Madsen-Bouterse","year":"2008","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ymthe.2026.01.015_bib55","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.01.015_bib56","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in Signaling and Disease: Beyond Discovery and Development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.01.015_bib57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.01.015_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe1433","article-title":"Prosaposin mediates inflammation in atherosclerosis","volume":"13","author":"van Leent","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.01.015_bib59","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1073\/pnas.0903120106","article-title":"Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1","volume":"106","author":"Kang","year":"2009","journal-title":"P Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.01.015_bib60","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1182\/blood-2007-08-110205","article-title":"Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor","volume":"111","author":"Acevedo","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.01.015_bib61","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1172\/JCI58976","article-title":"Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice","volume":"122","author":"Maione","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.01.015_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020997","article-title":"Hemopexin and Cancer","volume":"23","author":"Fiorito","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.01.015_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108181","article-title":"Scavenging of Labile Heme by Hemopexin Is a Key Checkpoint in Cancer Growth and Metastases","volume":"32","author":"Canesin","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.01.015_bib64","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000360085","article-title":"Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis","volume":"51","author":"Li","year":"2014","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.ymthe.2026.01.015_bib65","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5693-2","article-title":"Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma","volume":"19","author":"Burgos-Panadero","year":"2019","journal-title":"Bmc Cancer"},{"key":"10.1016\/j.ymthe.2026.01.015_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030633","article-title":"Neurodegeneration, Neuroprotection and Regeneration in the Zebrafish Retina","volume":"10","author":"Stella","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2026.01.015_bib67","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.01.015_bib68","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/j.ophtha.2020.01.029","article-title":"Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration Two-Year Results","volume":"127","author":"Martin","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.01.015_bib69","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.01.015_bib70","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/iovs.62.10.18","article-title":"Analysis of the Aqueous Humor Proteome in Patients With Age-Related Macular Degeneration","volume":"62","author":"Rinsky","year":"2021","journal-title":"Invest Ophth Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.01.015_bib71","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1167\/iovs.10-5531","article-title":"Proteome Analysis of Human Aqueous Humor","volume":"51","author":"Chowdhury","year":"2010","journal-title":"Invest Ophth Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.01.015_bib72","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1167\/iovs.03-1048","article-title":"Prosaposin gene expression in normal and dystrophic RCS rat retina","volume":"45","author":"Van den Berghe","year":"2004","journal-title":"Invest Ophth Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.01.015_bib73","doi-asserted-by":"crossref","first-page":"9593","DOI":"10.1073\/pnas.91.20.9593","article-title":"Identification of prosaposin as a neurotrophic factor","volume":"91","author":"O'Brien","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ymthe.2026.01.015_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114656","article-title":"Intranasal administration of recombinant prosaposin attenuates neuronal apoptosis through GPR37\/PI3K\/Akt\/ASK1 pathway in MCAO rats","volume":"373","author":"Yu","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2026.01.015_bib75","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1073\/pnas.1219004110","article-title":"GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin","volume":"110","author":"Meyer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.01.015_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.08.022","article-title":"The protective role of prosaposin and its receptors in the nervous system","volume":"1585","author":"Meyer","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2026.01.015_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/nu12103142","article-title":"Vitamin C and the Lens: New Insights into Delaying the Onset of Cataract","volume":"12","author":"Lim","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ymthe.2026.01.015_bib78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exer.2014.04.022","article-title":"Polymorphisms in sodium-dependent vitamin C transporter genes and plasma, aqueous humor and lens nucleus ascorbate concentrations in an ascorbate depleted setting","volume":"124","author":"Senthilkumari","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2026.01.015_bib79","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.1021\/acs.analchem.2c00679","article-title":"Sickle-like Inertial Microfluidic System for Online Rare Cell Separation and Tandem Label-Free Quantitative Proteomics (Orcs-Proteomics)","volume":"94","author":"Wang","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ymthe.2026.01.015_bib80","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162600016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162600016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:20:30Z","timestamp":1788178830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162600016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S152500162600016X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.015","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prosaposin is a dual-action therapeutic target for vascular stabilization and neuroprotection","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}